Ho Jin Kim

13.0k total citations · 3 hit papers
172 papers, 5.9k citations indexed

About

Ho Jin Kim is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Ho Jin Kim has authored 172 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 142 papers in Pathology and Forensic Medicine, 100 papers in Neurology and 46 papers in Rheumatology. Recurrent topics in Ho Jin Kim's work include Multiple Sclerosis Research Studies (137 papers), Peripheral Neuropathies and Disorders (88 papers) and Systemic Lupus Erythematosus Research (39 papers). Ho Jin Kim is often cited by papers focused on Multiple Sclerosis Research Studies (137 papers), Peripheral Neuropathies and Disorders (88 papers) and Systemic Lupus Erythematosus Research (39 papers). Ho Jin Kim collaborates with scholars based in South Korea, United States and Germany. Ho Jin Kim's co-authors include Su‐Hyun Kim, Jae‐Won Hyun, Woojun Kim, AeRan Joung, So‐Young Huh, Michael Levy, In Hye Jeong, Friedemann Paul, Kazuo Fujihara and Brian G. Weinshenker and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ho Jin Kim

163 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum Disorder

2019 536 citations Sean J. Pittock, Kazuo Fujihara et al. profile →
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing

2018 502 citations Friedemann Paul, Kazuo Fujihara et al. profile →
Neuromyelitis optica

2020 276 citations Friedemann Paul, Ho Jin Kim et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ho Jin Kim South Korea	41	4.3k	3.4k	1.3k	914	654	172	5.9k
Hans-Peter Hartung Germany	42	5.2k 1.2×	2.7k 0.8×	1.5k 1.1×	1.9k 2.0×	1.1k 1.7×	83	7.6k
Christian A. Vedeler Norway	38	1.6k 0.4×	2.8k 0.8×	521 0.4×	1.0k 1.1×	1.4k 2.1×	196	6.1k
Luca Durelli Italy	33	2.4k 0.6×	1.7k 0.5×	937 0.7×	766 0.8×	405 0.6×	121	4.2k
Gavin Giovannoni United Kingdom	10	3.5k 0.8×	1.2k 0.3×	878 0.7×	1.1k 1.2×	735 1.1×	20	4.6k
Martin S. Weber Germany	41	2.6k 0.6×	1.1k 0.3×	640 0.5×	2.6k 2.8×	967 1.5×	150	5.4k
Bibiana Bielekova United States	38	2.9k 0.7×	856 0.3×	756 0.6×	3.1k 3.4×	1.1k 1.7×	103	6.0k
Brian Patrick O’Neill United States	54	3.1k 0.7×	4.4k 1.3×	293 0.2×	434 0.5×	1.6k 2.5×	164	9.4k
Paolo Gallo Italy	23	1.9k 0.4×	637 0.2×	459 0.3×	491 0.5×	1.4k 2.1×	106	3.7k
Samira Saadoun United Kingdom	35	2.1k 0.5×	1.3k 0.4×	294 0.2×	440 0.5×	2.6k 4.0×	70	5.8k
Andreas Bitsch Germany	25	1.8k 0.4×	768 0.2×	456 0.3×	727 0.8×	643 1.0×	48	3.4k

Countries citing papers authored by Ho Jin Kim

Since Specialization

Citations

This map shows the geographic impact of Ho Jin Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ho Jin Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ho Jin Kim more than expected).

Fields of papers citing papers by Ho Jin Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ho Jin Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ho Jin Kim. The network helps show where Ho Jin Kim may publish in the future.

Co-authorship network of co-authors of Ho Jin Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Ho Jin Kim. A scholar is included among the top collaborators of Ho Jin Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ho Jin Kim. Ho Jin Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kim, Ki Hoon, et al.. (2025). Discontinuation of Immunotherapy in Patients With Relapsing Myelitis Without AQP4/MOG Antibodies. Annals of Clinical and Translational Neurology. 12(8). 1689–1692. 1 indexed citations

Bennett, Jeffrey L., Sean J. Pittock, Friedemann Paul, et al.. (2024). B cell and aquaporin‐4 antibody relationships with neuromyelitis optica spectrum disorder activity. Annals of Clinical and Translational Neurology. 11(10). 2792–2798. 4 indexed citations

Kim, Su‐Hyun, Beung‐Chul Ahn, Dong-Eun Lee, et al.. (2024). Blood Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Promising Screening Biomarkers for Brain Metastases in Patients with Lung Cancer. International Journal of Molecular Sciences. 25(12). 6397–6397. 3 indexed citations

Kim, Ki Hoon, Eun Young Park, Ho‐Shin Gwak, et al.. (2024). Disseminating Necrotizing Leukoencephalopathy Associated With Intra-CSF Methotrexate Chemotherapy. Neurology. 102(5). e209167–e209167. 3 indexed citations

Fujihara, Kazuo, Ho Jin Kim, Takahiko Saida, et al.. (2023). Efficacy and safety of inebilizumab in Asian participants with neuromyelitis optica spectrum disorder: Subgroup analyses of the N-MOmentum study. Multiple Sclerosis and Related Disorders. 79. 104938–104938. 5 indexed citations

Kim, Ki Hoon, Su‐Hyun Kim, Na-Young Park, Jae‐Won Hyun, & Ho Jin Kim. (2022). Onset of various CNS inflammatory demyelination diseases following COVID-19 vaccinations. Multiple Sclerosis and Related Disorders. 68. 104141–104141. 8 indexed citations

Kim, Ki Hoon, et al.. (2022). Seroprevalence of anti‐myelin oligodendrocyte glycoprotein antibodies in adults with myelitis. Annals of Clinical and Translational Neurology. 9(9). 1481–1486. 3 indexed citations

Huh, So‐Young, Su‐Hyun Kim, Ki Hoon Kim, et al.. (2022). Safety and Temporal Pattern of the Lymphocyte Count During Fingolimod Therapy in Patients With Multiple Sclerosis: Real-World Korean Experience. Journal of Clinical Neurology. 18(6). 663–663. 3 indexed citations

Lee, Hye Lim, Su‐Hyun Kim, Jin Myoung Seok, et al.. (2022). Results of a Survey on Diagnostic Procedures and Treatment Choices for Neuromyelitis Optica Spectrum Disorder in Korea: Beyond the Context of Current Clinical Guidelines. Journal of Clinical Neurology. 18(2). 207–207. 5 indexed citations

10.

Hyun, Jae‐Won, Yeseul Kim, & Ho Jin Kim. (2021). Investigation of serum biomarkers for neuropathic pain in neuromyelitis optica spectrum disorder: a preliminary study. 23(1). 46–52. 2 indexed citations

11.

Hyun, Jae‐Won, Hye Lim Lee, Jae-Hong Park, et al.. (2021). Brighter spotty lesions on spinal MRI help differentiate AQP4 antibody-positive NMOSD from MOGAD. Multiple Sclerosis Journal. 28(6). 989–992. 10 indexed citations

12.

Hyun, Jae‐Won, et al.. (2021). Absence of attack-independent neuroaxonal injury in MOG antibody-associated disease: Longitudinal assessment of serum neurofilament light chain. Multiple Sclerosis Journal. 28(6). 993–999. 8 indexed citations

13.

Kim, Yeseul, Ha Eun Kim, Su‐Hyun Kim, et al.. (2021). Functional impairment of CD19 ⁺ CD24 ^hi CD38 ^hi B cells in neuromyelitis optica spectrum disorder is restored by B cell depletion therapy. Science Translational Medicine. 13(624). eabk2132–eabk2132. 10 indexed citations

14.

Kim, Ki Hoon, Su‐Hyun Kim, Na-Young Park, Jae‐Won Hyun, & Ho Jin Kim. (2021). Reappraisal of CSF-specific oligoclonal bands in Asia. Multiple Sclerosis Journal. 28(4). 665–668. 3 indexed citations

15.

Kim, Woojun, Eun Young Park, Jae‐Won Hyun, et al.. (2020). Validation of the Korean Version of the 12-Item Multiple Sclerosis Walking Scale and Application to Neuromyelitis Optica Spectrum Disorder. Journal of Clinical Neurology. 16(2). 270–270. 5 indexed citations

16.

Hyun, Jae‐Won, et al.. (2020). Incidence of interattack asymptomatic brain lesions in NMO spectrum disorder. Neurology. 95(23). e3124–e3128. 30 indexed citations

17.

Hyun, Jae‐Won, Na-Young Park, Su‐Hyun Kim, et al.. (2020). Comparison of Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis. Journal of Clinical Neurology. 16(1). 124–124. 17 indexed citations

18.

Choi, Sun Ah, Soo Yeon Kim, Hunmin Kim, et al.. (2020). Clinical Spectrum of Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Associated Disease in Korean Children. Journal of Clinical Neurology. 16(3). 461–461. 6 indexed citations

19.

Kim, Su‐Hyun, Yeseul Kim, Ji Yun Jung, et al.. (2019). High Seroprevalence and Index of Anti-John-Cunningham Virus Antibodies in Korean Patients with Multiple Sclerosis. Journal of Clinical Neurology. 15(4). 454–454. 5 indexed citations

20.

Kim, Jason Yongha, et al.. (2013). Association analysis of IL7R polymorphisms with inflammatory demyelinating diseases. Molecular Medicine Reports. 9(2). 737–743. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact